(Q41217469)

28 September 2017

title

Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB. (English)

1 reference

28 September 2017

1 reference

S Muthukkumar

1

1 reference

28 September 2017

S F Sells

series ordinal

2

1 reference

28 September 2017

S A Crist

series ordinal

3

1 reference

28 September 2017

V M Rangnekar

series ordinal

4

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

Journal of Biological Chemistry

28 September 2017

published in

1 reference

28 September 2017

volume

271

1 reference

28 September 2017

issue

10

1 reference

28 September 2017

page(s)

5733-5740

1 reference

Interleukin 1: the first interleukin.

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Interleukin 1 modulates growth of human renal carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Interleukin 1 signaling occurs exclusively via the type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The two different receptors for tumor necrosis factor mediate distinct cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Signal transduction by tumor necrosis factor mediated by JNK protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Specific enzymatic dephosphorylation of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

The transcription factor E2F-1 is a downstream target of RB action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.10.5733

21 January 2018

Identifiers

DOI

10.1074/JBC.271.10.5733

1 reference

28 September 2017

1 reference